ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Net Income
Bottom-line profit after all expenses, interest, and taxes.
No reported Net Income figures are available to summarize.
Net Income history
Currency unavailable · from the income statement
No Net Income data reported for this period type.
Net Income vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -€45.62M EUR | -51.2% | — | 339.4% | |
| LTM Mar 2026 | -$48.88M USD | -44.5% | — | — | |
| FY2025 | -$76.68M USD | — | — | 411.9% | |
| LTM Mar 2026 | -$78.67M USD | -15.4% | — | 173.5% | |
| LTM Mar 2026 | -$85.17M USD | — | — | 9243.0% | |
| LTM Mar 2026 | -$120.53M USD | +28.0% | — | 151.1% | |
| LTM Mar 2026 | -$169.77M USD | -437.7% | — | 529.2% | |
| LTM Mar 2026 | -$183.59M USD | -63.4% | — | 255.7% | |
| LTM Mar 2026 | -$198.37M USD | +1.8% | — | 4917.6% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -44.5% | — | 375.6% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.